長期投資家のためのIR情報
 バリュートレンド
  1. HOME
  2. バリュートレンド
  3. 【4574】大幸薬品

【4574】大幸薬品
製薬。『正露丸』
類似企業：
【業界1位】 小野薬品工業
【売上同水準】 中京医薬品 シンバイオ製薬


東証プライム
医薬
＞
医他
売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
決算期 日付 予・実 売上高
(百万円)		 対前回 修正率 修正率 営業利益
(百万円)		 対前回 修正率 修正率 経常利益
(百万円)		 対前回 修正率 修正率 当期利益
(百万円)		 対前回 修正率 修正率
2024.12 2024/11/08 Q3予 6,800 → 0.0% 0.0% 550 → 0.0% +34.1% 590 → 0.0% +43.9% 550 → 0.0% +57.1%
2024.12 2024/08/09 Q2予 6,800 → 0.0% 0.0% 550 ↑ +34.1% +34.1% 590 ↑ +63.9% +43.9% 550 → 0.0% +57.1%
2024.12 2024/05/10 Q1予 6,800 → 0.0% 0.0% 410 → 0.0% 0.0% 360 → 0.0% -12.2% 550 → 0.0% +57.1%
2024.12 2024/03/07 修正予 6,800 → 0.0% 0.0% 410 → 0.0% 0.0% 360 ↓ -12.2% -12.2% 550 ↑ +57.1% +57.1%
2024.12 2024/02/09 当初予 6,800 - - - 410 - - - 410 - - - 350 - - -
2023.12 2024/02/09 実 6,120 ↓ -4.4% -22.5% -1,005 ↓ -25.6% -288.9% -1,248 ↓ -24.8% -334.6% -3,611 ↓ -280.1% -7322.0%
2023.12 2023/11/10 Q3予 6,400 ↓ -19.0% -19.0% -800 ↓ -250.4% -250.4% -1,000 ↓ -1766.7% -288.0% -950 ↓ -2000.0% -2000.0%
2023.12 2023/08/10 Q2予 7,900 → 0.0% 0.0% 532 → 0.0% 0.0% 60 → 0.0% -88.7% 50 → 0.0% 0.0%
2023.12 2023/05/12 Q1予 7,900 → 0.0% 0.0% 532 → 0.0% 0.0% 60 ↓ -88.7% -88.7% 50 → 0.0% 0.0%
2023.12 2023/02/10 当初予 7,900 - - - 532 - - - 532 - - - 50 - - -
2022.12 2023/02/10 実 5,040 ↓ -16.0% -16.0% -3,079 ↓ -10.0% -10.0% -3,352 ↓ -11.7% -11.7% -4,895 ↓ -48.3% -48.3%
2022.12 2022/11/11 Q3予 6,000 → 0.0% 0.0% -2,800 → 0.0% 0.0% -3,000 → 0.0% 0.0% -3,300 → 0.0% 0.0%
2022.12 2022/08/12 当初予 6,000 - - - -2,800 - - - -3,000 - - - -3,300 - - -
2021.12 2022/02/18 実 11,299 ↓ -9.6% -48.6% -4,947 ↓ -147.4% -209.9% -6,131 ↓ -80.3% -239.3% -9,594 ↓ -242.6% -409.5%
2021.12 2021/11/09 Q3予 12,500 → 0.0% -43.2% -2,000 → 0.0% -144.4% -3,400 → 0.0% -177.3% -2,800 → 0.0% -190.3%
2021.12 2021/08/06 Q2予 12,500 ↓ -43.2% -43.2% -2,000 ↓ -144.4% -144.4% -3,400 ↓ -177.3% -177.3% -2,800 ↓ -190.3% -190.3%
2021.12 2021/05/07 Q1予 22,000 → 0.0% 0.0% 4,500 → 0.0% 0.0% 4,400 → 0.0% 0.0% 3,100 → 0.0% 0.0%
2021.12 2021/02/12 当初予 22,000 - - - 4,500 - - - 4,400 - - - 3,100 - - -
2020.12 2021/02/12 実 17,582 ↓ -2.3% +30.2% 5,650 ↑ +2.7% +52.7% 5,454 ↑ +2.9% +55.8% 3,851 ↑ +1.3% +54.0%
2020.12 2020/11/12 Q2予 18,000 → 0.0% +33.3% 5,500 → 0.0% +48.6% 5,300 → 0.0% +51.4% 3,800 → 0.0% +52.0%
2020.12 2020/08/12 修正予 18,000 ↑ +33.3% +33.3% 5,500 ↑ +48.6% +48.6% 5,300 ↑ +51.4% +51.4% 3,800 ↑ +52.0% +52.0%
2020.12 2020/05/12 当初予 13,500 - - - 3,700 - - - 3,500 - - - 2,500 - - -
2020.03 2020/05/12 実 14,966 ↑ +10.0% +32.9% 3,824 ↑ +27.5% +73.8% 3,633 ↑ +32.1% +86.3% 2,453 ↑ +32.6% +72.7%
2020.03 2020/02/10 修正予 13,600 ↑ +20.8% +20.8% 3,000 ↑ +36.4% +36.4% 2,750 ↑ +41.0% +41.0% 1,850 ↑ +30.3% +30.3%
2020.03 2019/11/08 Q2予 11,260 → 0.0% 0.0% 2,200 → 0.0% 0.0% 1,950 → 0.0% 0.0% 1,420 → 0.0% 0.0%
2020.03 2019/08/09 Q1予 11,260 → 0.0% 0.0% 2,200 → 0.0% 0.0% 1,950 → 0.0% 0.0% 1,420 → 0.0% 0.0%
2020.03 2019/05/14 当初予 11,260 - - - 2,200 - - - 1,950 - - - 1,420 - - -
2019.03 2019/05/14 実 10,418 ↑ +0.2% +11.3% 2,029 ↑ +1.4% +24.5% 1,885 ↑ +1.9% +31.8% 1,415 ↑ +1.1% +40.1%
2019.03 2019/03/15 修正予 10,400 ↑ +11.1% +11.1% 2,000 ↑ +22.7% +22.7% 1,850 ↑ +29.4% +29.4% 1,400 ↑ +38.6% +38.6%
2019.03 2019/02/08 Q3予 9,360 → 0.0% 0.0% 1,630 → 0.0% 0.0% 1,430 → 0.0% 0.0% 1,010 → 0.0% 0.0%
2019.03 2018/11/09 Q2予 9,360 → 0.0% 0.0% 1,630 → 0.0% 0.0% 1,430 → 0.0% 0.0% 1,010 → 0.0% 0.0%
2019.03 2018/08/10 Q1予 9,360 → 0.0% 0.0% 1,630 - - - 1,430 → 0.0% 0.0% 1,010 → 0.0% 0.0%
2019.03 2018/05/11 当初予 9,360 - - - - - - - 1,430 - - - 1,010 - - -
2018.03 2018/05/11 実 - - - - - - - - - - - - - - - -
2018.03 2018/02/09 Q3予 8,700 → 0.0% 0.0% 1,550 → 0.0% 0.0% 1,300 → 0.0% 0.0% 900 → 0.0% 0.0%
2018.03 2017/11/10 Q2予 8,700 → 0.0% 0.0% 1,550 → 0.0% 0.0% 1,300 → 0.0% 0.0% 900 → 0.0% 0.0%
2018.03 2017/08/10 Q1予 8,700 → 0.0% 0.0% 1,550 → 0.0% 0.0% 1,300 → 0.0% 0.0% 900 → 0.0% 0.0%
2018.03 2017/05/12 当初予 8,700 - - - 1,550 - - - 1,300 - - - 900 - - -
2017.03 2017/05/12 実 8,294 ↓ -1.3% -1.3% 1,545 ↑ +14.4% +14.4% 1,407 ↑ +26.8% +26.8% 1,049 ↑ +23.4% +23.4%
2017.03 2017/02/10 Q3予 8,400 → 0.0% 0.0% 1,350 → 0.0% 0.0% 1,110 → 0.0% 0.0% 850 → 0.0% 0.0%
2017.03 2016/11/11 Q2予 8,400 → 0.0% 0.0% 1,350 → 0.0% 0.0% 1,110 → 0.0% 0.0% 850 → 0.0% 0.0%
2017.03 2016/08/12 Q1予 8,400 → 0.0% 0.0% 1,350 → 0.0% 0.0% 1,110 → 0.0% 0.0% 850 → 0.0% 0.0%
2017.03 2016/05/13 当初予 8,400 - - - 1,350 - - - 1,110 - - - 850 - - -
2016.03 2016/05/13 実 8,327 ↓ -9.5% -9.5% 1,347 ↓ -13.1% -13.1% 1,307 ↓ -9.9% -9.9% 840 ↓ -16.0% -16.0%
2016.03 2016/02/12 Q3予 9,200 → 0.0% 0.0% 1,550 → 0.0% 0.0% 1,450 → 0.0% 0.0% 1,000 → 0.0% 0.0%
2016.03 2015/11/12 Q2予 9,200 → 0.0% 0.0% 1,550 → 0.0% 0.0% 1,450 → 0.0% 0.0% 1,000 → 0.0% 0.0%
2016.03 2015/08/12 Q1予 9,200 → 0.0% 0.0% 1,550 → 0.0% 0.0% 1,450 → 0.0% 0.0% 1,000 → 0.0% 0.0%
2016.03 2015/05/13 当初予 9,200 - - - 1,550 - - - 1,450 - - - 1,000 - - -
2015.03 2015/05/13 実 8,978 ↑ +0.9% +9.5% 2,559 ↑ +16.3% +64.0% 2,776 ↑ +18.1% +77.9% 1,770 ↑ +18.0% +77.0%
2015.03 2015/02/12 Q3予 8,900 → 0.0% +8.5% 2,200 → 0.0% +41.0% 2,350 → 0.0% +50.6% 1,500 → 0.0% +50.0%
2015.03 2015/02/05 修正予 8,900 ↑ +8.5% +8.5% 2,200 ↑ +41.0% +41.0% 2,350 ↑ +50.6% +50.6% 1,500 ↑ +50.0% +50.0%
2015.03 2014/11/12 Q2予 8,200 → 0.0% 0.0% 1,560 → 0.0% 0.0% 1,560 → 0.0% 0.0% 1,000 → 0.0% 0.0%
2015.03 2014/08/12 Q1予 8,200 → 0.0% 0.0% 1,560 → 0.0% 0.0% 1,560 → 0.0% 0.0% 1,000 → 0.0% 0.0%
2015.03 2014/05/13 当初予 8,200 - - - 1,560 - - - 1,560 - - - 1,000 - - -
2014.03 2014/05/13 実 9,947 ↑ +8.1% +8.1% 2,590 ↑ +17.7% +17.7% 2,683 ↑ +19.2% +19.2% 1,747 ↑ +21.3% +21.3%
2014.03 2014/02/05 当初予 9,200 - - - 2,200 - - - 2,250 - - - 1,440 - - -
シェア ツイート
ページトップへ戻る